Global Pharmaceuticals & Biotech Leverage Leaders

Financière de Tubize

Market Cap: €9.4b

Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.

SCHOTT Pharma KGaA

Market Cap: €2.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Stevanato Group

Market Cap: US$5.7b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥419.0b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

ADMA Biologics

Market Cap: US$4.3b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Exelixis

Market Cap: US$11.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

ACADIA Pharmaceuticals

Market Cap: US$4.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Vaxcyte

Market Cap: US$6.0b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Biogen

Market Cap: US$25.6b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

D&D Pharmatech

Market Cap: ₩4.1t

A clinical-stage biotech company, develops medicines in South Korea and the United States.

Asymchem Laboratories (Tianjin)

Market Cap: CN¥33.7b

Asymchem Laboratories (Tianjin) Co., Ltd.

Imeik Technology DevelopmentLtd

Market Cap: CN¥43.7b

Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.

Corcept Therapeutics

Market Cap: US$3.7b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Aurobindo Pharma

Market Cap: ₹701.3b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

Kalbe Farma

Market Cap: Rp55.5t

Develops, manufactures, and trades in pharmaceutical products in Indonesia.

Alkem Laboratories

Market Cap: ₹663.9b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Otsuka Holdings

Market Cap: JP¥4.7t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Tasly Pharmaceutical Group

Market Cap: CN¥22.8b

Researches, develops, manufactures, and sells medicines and related pharmaceuticals in China and internationally.

Sun Pharmaceutical Industries

Market Cap: ₹4.2t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥37.9b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Bachem Holding

Market Cap: CHF 4.4b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

Camurus

Market Cap: SEK 36.4b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Krka d. d

Market Cap: €6.2b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

Viridian Therapeutics

Market Cap: US$2.9b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

United Therapeutics

Market Cap: US$21.1b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

IDEAYA Biosciences

Market Cap: US$3.1b

A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

Structure Therapeutics

Market Cap: US$4.3b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

Kiniksa Pharmaceuticals International

Market Cap: US$3.1b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

Wave Life Sciences

Market Cap: US$2.7b

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥16.4b

Operates as contract development and manufacturing organization (CDMO) company in China and internationally.

Peptron

Market Cap: ₩6.0t

Engages in the development of peptide-based medicines.

Chugai Pharmaceutical

Market Cap: JP¥14.0t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Catalyst Pharmaceuticals

Market Cap: US$2.8b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Beam Therapeutics

Market Cap: US$2.6b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

Daiichi Sankyo Company

Market Cap: JP¥6.5t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Jiangsu Nhwa Pharmaceutical

Market Cap: CN¥24.8b

Engages in production, marketing, and services related to central nervous system drugs in China.